about
Methionine deficiency and hepatic injury in a dietary steatohepatitis modelRole of mitochondria in nonalcoholic fatty liver diseaseBiochemical mechanism underlying hypertriglyceridemia and hepatic steatosis/hepatomegaly induced by acute schisandrin B treatment in miceMammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylationHas natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis.Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet.Effects of resveratrol in experimental and clinical non-alcoholic fatty liver diseaseIncreased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver diseaseHistopathology of nonalcoholic fatty liver disease.The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicityPresence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.Update on fatty liver disease and steatohepatitis.Association between vitamin E and non-alcoholic steatohepatitis: a meta-analysis.Review article: hepatic steatosis and insulin resistance.From fatty liver to fibrosis: a tale of "second hit".Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion.JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis.Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equalApoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications.Hepatocellular ballooning in nonalcoholic steatohepatitis: the pathologist's perspective.Nonalcoholic fatty liver disease: current issues and novel treatment approaches.Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease.Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitisMechanisms and clinical implications of hepatocyte lipoapoptosis.LRP1 Protein Deficiency Exacerbates Palmitate-induced Steatosis and Toxicity in Hepatocytes.Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.Decreased ANT content in Zucker fatty rats: relevance for altered hepatic mitochondrial bioenergetics in steatosis.Cytochrome c release from rat liver mitochondria is compromised by increased saturated cardiolipin species induced by sucrose feeding.Vitamin E as a Treatment for Nonalcoholic Fatty Liver Disease: Reality or Myth?miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease
P2860
Q24650636-56950A71-2DFD-4DCF-947B-2A6247174791Q27028142-28899F46-E6D4-4458-84A9-84CBE653C6CDQ28468601-FAA71CD9-4CC5-4F5E-93CF-CD5787C367FBQ28586153-28F272CD-0011-4543-BAC7-D908A2FB1296Q30443852-2DCE8923-68C0-415B-858F-30C1E8A0ED6EQ30447993-B832668B-46BB-4FD3-93EB-82D24CD53ECCQ33372436-F7B6F8B1-2E30-4031-87DC-7CC780379A82Q33563877-52A18899-9A45-4108-B162-515721750A5FQ34069352-DEFFE06B-65D7-4FFB-B81F-42DDF39B293FQ34306736-7143081F-F3D8-4F5E-8419-4D083F1BCA13Q34512981-F6DBDA30-C3CB-4D7D-B0AF-A573AAEB795BQ35115991-AD9B78BD-5D5C-454B-8B54-4F8E6B8BEDF4Q35119509-B141BE7C-13F4-47D7-9F22-687A140E8097Q35643797-F03085B6-2DBB-4AFE-848D-84AE6EB381A6Q36286327-841BD946-2F31-4454-8572-6FE2509BE62AQ36654446-9126A241-AC8F-41B5-A571-893036B7F32BQ36734086-FA30D8A9-5B23-4F17-8F65-7ADC74C6ECD2Q37337683-F4C1622E-6340-481D-A5C1-ACA878AC5E7CQ37446730-EDD77ADC-299F-451C-BEA0-904CE3A966A7Q37578517-FE84A3C6-9B4D-486D-937C-66861A18A120Q37863133-ECC06017-B0A5-41B0-AD4E-0154FD8A40E6Q37863136-2B8D3950-C198-41E8-B151-C662ED5A559CQ38074898-DA35239B-0FCF-464D-8C9A-25563C4356FFQ38202220-FDDE7F53-4546-4471-A9C4-C97DAD29F1B3Q38699261-F830BA8F-3841-4B76-9A80-463B3B7E1CAFQ39845029-9E82F745-AC0B-462F-BF04-1408E6B551BCQ41787664-7E7D3B9D-872D-471C-AF66-724B6C2FB8F9Q43294210-20CB49C7-22C5-4C50-BA67-8BE6E7B09EC4Q43912178-9CD3B1B2-C3CA-449C-8CCC-AF02A5F8B3F7Q46672262-6EA5776E-E1D4-411B-B6DC-AF370149C56DQ49367065-46305198-E78C-4CCF-9E54-A8E0B2F83C7EQ58604344-B4473C60-C650-47B4-9677-FF91243DA02D
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Mitochondria in nonalcoholic fatty liver disease.
@ast
Mitochondria in nonalcoholic fatty liver disease.
@en
type
label
Mitochondria in nonalcoholic fatty liver disease.
@ast
Mitochondria in nonalcoholic fatty liver disease.
@en
prefLabel
Mitochondria in nonalcoholic fatty liver disease.
@ast
Mitochondria in nonalcoholic fatty liver disease.
@en
P2093
P1476
Mitochondria in nonalcoholic fatty liver disease.
@en
P2093
Charissa Y Chang
Lisa Krugner-Higby
Robert K Nakamoto
Stephen H Caldwell
P304
595-617, x
P356
10.1016/J.CLD.2004.04.009
P577
2004-08-01T00:00:00Z